Biomerica (BMRA) FCF Margin Growth (3y) (2013 - 2026)
Biomerica (BMRA) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 417.00 |
| 10 | Biomerica | 5.57 Mn | 4.23 Mn | -44,000.00 | 2,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2,916.00 |
| Nov 30, 2025 | 157.00 |
| Aug 31, 2025 | 7,875.00 |
| May 31, 2025 | -751.00 |
| Feb 28, 2025 | -12,398.00 |
| Nov 30, 2024 | 1,391.00 |
| Aug 31, 2024 | -7,998.00 |
| May 31, 2024 | 267.00 |
| Feb 29, 2024 | -13,826.00 |
| Nov 30, 2023 | 4,097.00 |
| Aug 31, 2023 | 4,412.00 |
| May 31, 2023 | 4,154.00 |
| Feb 28, 2023 | -11,686.00 |
| Nov 30, 2022 | -6,079.00 |
| Aug 31, 2022 | -9,730.00 |
| May 31, 2022 | 628.00 |
| Feb 28, 2022 | 5,252.00 |
| Nov 30, 2021 | -4,498.00 |
| Aug 31, 2021 | 6,804.00 |
| May 31, 2021 | -6,492.00 |